Metabolic and Anti-inflammatory Response to Melatonin Administration in Patients with Diabetic Nephropathy.
CONCLUSION: Results of this study indicated that melatonin administration for 12 weeks in DN patients had beneficial effects on glycemic control, HDL-cholesterol, TAC and GSH levels, and gene expression of PPAR-γ, but did not affect other metabolic parameters.
PMID: 33492301 [PubMed - in process]
Source: Iranian Journal of Kidney Diseases - Category: Urology & Nephrology Tags: Iran J Kidney Dis Source Type: research
More News: Antidoxidants | Cholesterol | Clinical Trials | Diabetes | Endocrinology | Genetics | Insulin | Iran Health | Melatonin | Middle East Health | Study | Urology & Nephrology